Clinical Guidelines

The Oral GLP‑1 Era Has Arrived 

And chromatographers are about to be very busy…

Share

  • 1

    FDA's oral GLP-1 approval changes drug formulation approach.

  • 2

    Oral peptides need advanced stability and impurity profiling.

  • 3

    Increased analytical complexity raises expectations.

  • 4

    Impurities must be tracked to ensure efficacy.

  • 5

    Adopting innovative strategies like 2D chromatography is crucial.

  • 6

    Regulatory agencies demand deeper understanding of molecules.

  • 7

    Analytical uncertainty is a risk to business and compliance.

  • 8

    Collaboration in research is essential for progress.

Original Source(s)

The Oral GLP‑1 Era Has Arrived 

  • by Sean Orlowicz

  • March 12, 2026

Related Content

Sleep Duration Signals Metabolic Change

Weekend sleep recovery shows mixed metabolic associations depending on weekday sleep duration.

Empagliflozin Tested in Real-World Data

Investigators assess whether EMPA-REG findings extend to broader patients with type 2 diabetes.

SGLT2 Inhibitors Linked to Better Outcomes in Diabetes and Cirrhosis

A nationwide cohort study found lower rates of cardiorenal complications and hepatic decompensation